abbmira therapeutics develops small molecules to fine-tune native immunity to treat difficult to treat tumors and chronic diseases. Our investigational compound42 targets macrophages and repolarizes them towards an anti-tumor state.
Company Details
- Employees
- 1
- Founded
- 2024
- Address
- Basel, 4057, Ch
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.abbmira.com
- Keywords
- Inkocell Therapeutics.
- HQ
- Basel
Abbmira Therapeutics Questions
Abbmira Therapeutics's website is http://www.abbmira.com
Abbmira Therapeutics's LinkedIn profile is https://ch.linkedin.com/company/abbmira
Abbmira Therapeutics has
1 employees.
View email and phone details for 1
employees at Abbmira Therapeutics.
Abbmira Therapeutics's industry is
Biotechnology Research
Abbmira Therapeutics's top competitors are
Abc Biopply Ag,
Anaveon Ag,
Forenswiss,
Monte Rosa Therapeutics,
Orthosens,
Inkocell Therapeutics,
Amporin Pharmaceuticals,
Plusbiome Ag,
Altertainment,
Surface Cleantech.
Abbmira Therapeutics's categories are Biotechnology Research
Abbmira Therapeutics's founding year is 2024
